Literature DB >> 10902557

Feasibility of linear arrays for interstitial ultrasound thermal therapy.

R Chopra1, M J Bronskill, F S Foster.   

Abstract

The feasibility of linear array transducers for interstitial ultrasound thermal therapy was evaluated. Theoretical acoustic power distributions were used to calculate spatial heating patterns using the bioheat transfer equation. The spatial heating patterns of linear array and single element planar rectangular transducers were compared. Scanned heating with both transducer geometries produced asymmetric heating volumes; however, a more uniform radial temperature profile with a sharper margin was achieved with linear arrays. Single element transducers produced excessive heating near the probe surface. Homogeneous blood flow is predicted to reduce the mean temperature within the heated region, with little effect on the spatial pattern.

Mesh:

Year:  2000        PMID: 10902557     DOI: 10.1118/1.599006

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  64-element intraluminal ultrasound cylindrical phased array for transesophageal thermal ablation under fast MR temperature mapping: an ex vivo study.

Authors:  D Melodelima; R Salomir; C Mougenot; C Moonen; D Cathignol
Journal:  Med Phys       Date:  2006-08       Impact factor: 4.071

Review 2.  Modelling of endoluminal and interstitial ultrasound hyperthermia and thermal ablation: applications for device design, feedback control and treatment planning.

Authors:  Punit Prakash; Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2013-06       Impact factor: 3.914

3.  Modeling of Interstitial Ultrasound Ablation for Continuous Applicator Rotation With MR Validation.

Authors:  Katie Y Gandomi; Paulo A W G Carvalho; Matthew Tarasek; Eric W Fiveland; Chitresh Bhushan; Emery Williams; Paul Neubauer; Zhanyue Zhao; Julie Pilitsis; Desmond Yeo; Christopher J Nycz; Everette Burdette; Gregory S Fischer
Journal:  IEEE Trans Biomed Eng       Date:  2021-05-21       Impact factor: 4.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.